Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Coronary computed tomography angiography (CCTA)-derived fractional flow reserve (FFRCT) is endorsed by guidelines for the evaluation of obstructive coronary artery disease (OCAD) (1). However, real-world impact of selective use of FFRCT in patients with suspected OCAD by CCTA on subsequent invasive coronary angiography (ICA) and revascularization remains unclear. Purpose To assess the impact and diagnostic accuracy of FFRCT interpretation in patients with suspected OCAD by CCTA on downstream ICA and revascularization. Methods All consecutive patients who underwent coronary CCTA for the evaluation of stable chest pain between 01/10/2013 and 28/05/2021 in our tertiary university hospital were included in a registry. From a total population of 7541 patients, 1601 with reported anatomical obstructive OCAD on CCTA, were included in our study. OCAD was defined as the presence of a stenosis ≥ 50% in at least one of the three main vessels. CCTA were selectively send to FFRCT analysis according to radiologist's decision. A numerical interpretation of FFRCT was firstly performed by defining a lowest distal value≤ 0.8 as a possible need for revascularization and secondly, a comprehensive interpretation of FFRCT was completed by an experienced interventional cardiologist and radiologist. In brief, this interpretation takes into account not only the lowest distal FFRCT value, but also the post-stenotic FFR, the trans-lesional gradient and anatomical distribution of FFRCT changes. Results From a registry of 7541 patients, suspected OCAD derived from CCTA was reported in 1601 cases, including 808 (50.5%) patients evaluated by FFRCT. ICA was performed in 1160 (72.5%) and revascularization in 559 (34.9%) patients. Overall proportion of ICA decreased from 77.2 to 67.8% with FFRCT use (chi2 p<0.01) (Figure 1). After propensity score weighting, FFRCT use was independently associated with decreased ICA (OR: 0.66; 95% CI 0.53–0.83, p< 0.001) and with a decreased rate of myocardial revascularization (OR: 0.71; 95% CI 0.58 –0.88, p< 0.01). Compared to a numerical interpretation, a comprehensive assessment of FFRCT increased the ratio of revascularization per ICA (61.8 vs 50.2 %, p< 0.01) and was more accurate to rule-in OCAD patient requiring a myocardial revascularization (Figure 2). After propensity score adjustment, numerically abnormal FFRCT and pathological coronary disease distribution on comprehensive assessment similar were still independently associated with an increased the rate of ICA use (OR:3.03 95% CI 2.18–4.23, p< 0.001 and OR: 3.45; 95% CI 2.47–4.82, p< 0.001, respectively) and myocardial revascularization (OR:5.13; 95% CI 3.23–8.15, p< 0.001 and OR:6.48; 95% CI 4.55–9.22, p< 0.001, respectively). Conclusion We observed in a large single-center real-world registry that implementing FFRCT downstream ICA and that a comprehensive assessment of FFRCT ensures an improved selection of patients requiring myocardial revascularization.

Prevalence and clinical impact of major incidental findings detected on routine cardiovascular resonance imaging prior to catheter ablation of atrial fibrillation

Incidental Extracardiac Findings in Cardiac Computed Tomography Performed Before Radiofrequency Ablation of Atrial Fibrillation

Prevalance and impact of concomitant atrial fibrillation in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Coronary artery disease in atrial fibrillation ablation: impact on arrhythmic outcomes

Cardiac magnetic resonance for early atrial lesion visualization post atrial fibrillation radiofrequency catheter ablation

Prevalence and Impact of Concomitant Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

Association of left atrial strain by cardiovascular magnetic resonance with recurrence of atrial fibrillation following catheter ablation

The impact of peri-procedural imaging on safety and efficacy of atrial fibrillation ablation: insights from the Israeli AF Catheter Ablation Registry (ICAR)

Safety of Catheter Ablation of Atrial Fibrillation Without Pre‐ or Peri‐procedural Imaging for the Detection of Left Atrial Thrombus in the Era of Uninterrupted Anticoagulation

Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation

The impact of preoperative four-chamber strain on failure of the maze IV procedure for atrial fibrillation: insights from conventional and speckle-tracking echocardiography

18F-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography Imaging in Atrial Fibrillation: a Pilot Prospective Study.

Combined single-session cardiovascular magnetic resonance: stress perfusion and three-dimensional pulmonary vein angiography for stratification of atrial fibrillation patients with chest pain syndromes prior to catheter ablation

Abstract 17865: Machine Learning With Multimodal Pre Ablation Imaging for Predicting Recurrence in Atrial Fibrillation Patients

International Incidence of Complications after Catheter Ablation of Persistent Atrial Fibrillation (af): Insights from the Multicenter, Prospective, Randomized Star Af Ii Trial

Incidence of pulmonary vein stenosis after radiofrequency catheter ablation of atrial fibrillation

Impact of Catheter Ablation on Atrial Fibrillation Burden and Symptoms in Patients With Hypertrophic Cardiomyopathy

Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology

Catheter Ablation for Atrial Fibrillation in Patients with Significant Mitral Regurgitation: A Systematic Review and Meta-Analysis

Incidence and Outcomes of Cerebrovascular Events Complicating Catheter Ablation for Atrial Fibrillation

Incremental value of computed tomography angiographic derived fractional flow reserve in patients with stable chest pain and anatomical obstructive coronary artery disease